Leukemia

Choose a Subcategory

Take a free interactive course on CML

Cancer Drug Studied in Children with Rare Form of Leukemia

Read Article

The drug, STI-571, also known as Gleevec, was approved for the treatment of chronic myeloid leukemia, or CML, one of the four main types of leukemia.

Video	-	Taking Part in CML Trials Transcript
Video	-	New Strategies for Hard to Treat CML Transcript
Video	-	Emerging Therapies in CML Transcript
Video	-	Monitoring Therapy in Chronic Myeloid Leukemia Transcript
Ask Your Doctor	-	About Molecular-Targeted Therapies
Video	-	CML Therapy Update Transcript
Article	-	Cancer Drug Studied in Children with Rare Form of Leukemia
Article	-	New Drug for Rare, Hard-to-Treat Cancers
Did You Know	-	The number of cells containing the genetic defect in some leukemias can be reduced
Article	-	New Stem Cell Transplant Brings Hope to Children with Leukemia
Ask Your Doctor	-	About Treatment Issues in Chronic Myelogenous Leukemia
Article	-	Do Smoking Dads-to-Be Increase Leukemia Risk?
Article	-	Drug Errors Common in ALL Patients

Do you smoke cigarettes?

Yes